164 related articles for article (PubMed ID: 11217818)
41. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
Malyuk R; Gibson B; Procyshyn RM; Kang N
Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
[TBL] [Abstract][Full Text] [Related]
42. Anticonvulsant hypersensitivity syndrome (AHS): a case report.
Keel BR; Payne CL
Tenn Med; 2013 Apr; 106(4):35-6, 38. PubMed ID: 23617037
[TBL] [Abstract][Full Text] [Related]
43. Possible neuroleptic malignant syndrome associated with olanzapine.
Nyfort-Hansen K; Alderman CP
Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
[No Abstract] [Full Text] [Related]
44. Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity.
Troost RJ; Oranje AP; Lijnen RL; Benner R; Prens EP
Pediatr Dermatol; 1996; 13(4):316-20. PubMed ID: 8844754
[TBL] [Abstract][Full Text] [Related]
45. Marked elevation of serum creatine kinase associated with olanzapine therapy.
Marcus EL; Vass A; Zislin J
Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
[TBL] [Abstract][Full Text] [Related]
46. Adverse events related to olanzapine.
Conley RR; Meltzer HY
J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
[TBL] [Abstract][Full Text] [Related]
47. Olanzapine-induced agranulocytosis.
Naumann R; Felber W; Heilemann H; Reuster T
Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
[TBL] [Abstract][Full Text] [Related]
48. Neuroleptic malignant syndrome associated with olanzapine.
Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
[TBL] [Abstract][Full Text] [Related]
49. Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.
Gómez-Zorrilla S; Ferraz AV; Pedrós C; Lemus M; Peña C
Ann Pharmacother; 2012; 46(7-8):e20. PubMed ID: 22764327
[TBL] [Abstract][Full Text] [Related]
50. Olanzapine-induced mania.
Reeves RR; McBride WA; Brannon GE
J Am Osteopath Assoc; 1998 Oct; 98(10):549-50. PubMed ID: 9821737
[TBL] [Abstract][Full Text] [Related]
51. Olanzapine (Zyprexa): suspected serious reactions.
Cadario B
CMAJ; 2000 Jul; 163(1):85-6, 89-90. PubMed ID: 10920744
[No Abstract] [Full Text] [Related]
52. Olanzapine.
Hale AS
Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
[TBL] [Abstract][Full Text] [Related]
53. Overdose and death with olanzapine: two case reports.
Gerber JE; Cawthon B
Am J Forensic Med Pathol; 2000 Sep; 21(3):249-51. PubMed ID: 10990286
[TBL] [Abstract][Full Text] [Related]
54. [Acute hepatocellular lesion after successive exposure to clozapine and olanzapine in a patient with chronic hepatitis C infection].
Gómez Espín R; Sánchez Quiles I; Hallal H; Plaza J
Gastroenterol Hepatol; 2010 Feb; 33(2):150-2. PubMed ID: 19914745
[No Abstract] [Full Text] [Related]
55. Olanzapine-induced diabetes mellitus.
Bonanno DG; Davydov L; Botts SR
Ann Pharmacother; 2001 May; 35(5):563-5. PubMed ID: 11346063
[TBL] [Abstract][Full Text] [Related]
56. [Bullae induced by acute neuroleptic intoxication].
Boye T; Carsuzaa F
Ann Dermatol Venereol; 2000 Oct; 127(10):865. PubMed ID: 11060400
[No Abstract] [Full Text] [Related]
57. Olanzapine-lnduced hyperglycemic nonketonic coma.
Roefaro J; Mukherjee SM
Ann Pharmacother; 2001 Mar; 35(3):300-2. PubMed ID: 11261526
[TBL] [Abstract][Full Text] [Related]
58. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
Domon SE; Webber JC
J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
[TBL] [Abstract][Full Text] [Related]
59. [A case of mania following olanzapine administration].
Borysewicz K; Borysewicz W
Psychiatr Pol; 2000; 34(2):299-306. PubMed ID: 10974943
[TBL] [Abstract][Full Text] [Related]
60. [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
